{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:30:01Z","timestamp":1774305001536,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009457","name":"Region Sj\u00e6lland","doi-asserted-by":"publisher","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/501100009457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>This study was undertaken with the objective of comparing efficacy and safety for two different regimens using misoprostol for induction of labour.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The study was set in two different hospitals in the region of Zeeland, Denmark, and designed as a prospective cohort study. Nulliparous women with unripe cervix, eligible for vaginal delivery and medical induction of labour were included. Exclusion criteria were a previous uterine scar, suspicion of growth restriction of the fetus and prelabour rupture of membranes.<\/jats:p>\n<jats:p>One department used 25 mcg oral misoprostol tablets and the other department used 200 mcg slow-release misoprostol vaginal insert, for induction of labour.<\/jats:p>\n<jats:p>Primary outcomes were predefined as frequency of cesarean section, tachysystole and delivery within 24\u2009h. Secondary outcomes were: time from induction to delivery, use of additional methods for induction, postpartum hemorrhage, anal sphincter rupture, epidural, pyrexia (rectal temperature\u2009&gt;\u2009\u00a038.5\u2009\u00b0C), prolonged rupture of membranes, and use of tocolysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>No significant differences in women achieving vaginal delivery was found. However, a significantly increased risk of tachysystole for the vaginal administration route was observed; 28.4% compared with 2.3%. There were no events of serious neonatal asphyxia. Half of the women induced with vaginal insert delivered within 24\u2009h, compared with 16.8% of the women induced with oral misoprostol.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Induction with vaginal slow-release misoprostol leads to quicker delivery with an increased risk of tachysystole but with similar perinatal outcomes and rates of cesarean sections. Low-dose oral misoprostol appears to be safe, however it leads to an increased use of secondary methods and a tendency of more intrapartum pyrexia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>Clinicaltrials.gov ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02693587?term=NCT02693587&amp;draw=2&amp;rank=1\">NCT02693587<\/jats:ext-link> on February 262,016.<\/jats:p>\n<jats:p>EudraCT number 2020\u2013000366-42 on 23 January 2020, retrospectively registered.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12884-020-2770-0","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T09:04:30Z","timestamp":1581066270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Induction of labour in nulliparous women- quick or slow: a cohort study comparing slow-release vaginal insert with low-dose misoprostol oral tablets"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2929-4378","authenticated-orcid":false,"given":"Axelina","family":"Eriksson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"2770_CR1","unstructured":"Danish register of health (incl. births). Available online at: http:\/\/www.esundhed.dk\/sundhedsregistre\/MFR\/Sider\/MFR06A.aspx: Accessed Dec 18 2018."},{"key":"2770_CR2","unstructured":"NICE Guideline for induction of labour. Available online at: https:\/\/www.nice.org.uk\/guidance\/cg70\/chapter\/1-Guidance#recommended-methods-for-induction-of-labour. Accessed Dec 18 2018."},{"key":"2770_CR3","unstructured":"SOGC Guideline for induction of labour. Available online at: https:\/\/sogc.org\/wp-content\/uploads\/2013\/08\/September2013-CPG296-ENG-Online_REV-D.pdf. Accessed Dec 18 2018."},{"key":"2770_CR4","unstructured":"RCOG Guideline for induction of labour. Available online at: https:\/\/www.researchgate.net\/publication\/266045914_RCOG_Evidence-based_Clinical_Guidelines_Induction_of_labour. Accessed Dec 18 2018."},{"key":"2770_CR5","doi-asserted-by":"publisher","first-page":"CD001338","DOI":"10.1002\/14651858.CD 001338.pub3","volume":"6","author":"Z Alfirevic","year":"2014","unstructured":"Alfirevic Z, Aflaifel N, Weeks A. Oral misoprostol for induction of labor. Cochrane Database Syst Rev. 2014;6:CD001338. https:\/\/doi.org\/10.1002\/14651858.CD%20001338.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"2770_CR6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/j.1471-0528.2008.01872.x","volume":"115","author":"AS Souza","year":"2008","unstructured":"Souza AS, Amorim MM, Feitosa FE. Comparison of sublingual versus vaginal misoprostol for the induction of labour: a systematic review. BJOG. 2008;115:1340\u20139.","journal-title":"BJOG"},{"key":"2770_CR7","first-page":"164","volume":"34","author":"DS Gatt\u00e1s","year":"2012","unstructured":"Gatt\u00e1s DS, Souza AS, Souza CG, Florentino AV, N\u00f3brega BV, Fook VP, et al. Lowdose of sublingual misoprostol (12.5 \u03bcg) for laborinduction. Rev Bras Ginecol Obstet. 2012;34:164\u20139.","journal-title":"Rev Bras Ginecol Obstet"},{"key":"2770_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1447-0756.2009.01030.x","volume":"35","author":"KM Zahoursan","year":"2009","unstructured":"Zahoursan KM, Shahin AY, Abdellah MS, Elsayh KI. Sublingual versus vaginal misoprostol for induction of labor at term: a randomized prospective placebo-controlled study. J Obstet Gynaecol Res. 2009;35:1054\u201360.","journal-title":"J Obstet Gynaecol Res"},{"key":"2770_CR9","unstructured":"Thornton J. Available online at: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001338.pub3\/detailed-comment\/en?messageId=218459583. Accessed Nov 26 2019."},{"key":"2770_CR10","unstructured":"Rydahl E, Clausen JA. Available online at: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001338.pub3\/detailed-comment\/de?messageId=218459562. Accessed Nov 26, 2019."},{"key":"2770_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0091270007309707","volume":"48","author":"BL Powers","year":"2008","unstructured":"Powers BL, Wing DA, Carr D, Ewert K, Di Spirito M. Pharmacokinetic profiles of controlled-release hydrogen polymer vaginal inserts containing misoprostol. J Clin Pharmacol. 2008;48:26\u201334.","journal-title":"J Clin Pharmacol"},{"key":"2770_CR12","volume-title":"StatPearls","author":"KC Wormer","year":"2019","unstructured":"Wormer KC, Williford AE. StatPearls. Treasure Island: StatPearls Publishing; 2019."},{"key":"2770_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1471-0528.1999.tb08266.x","volume":"106","author":"P Lumbiganon","year":"1999","unstructured":"Lumbiganon P, Hofmeyr J, G\u00fclmezoglu AM, Pinol A, Villar J. Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO collaborative trial of misoprostol in the Management of the Third Stage of labour. Br J Obstet Gynaecol. 1999;106:304\u20138.","journal-title":"Br J Obstet Gynaecol"},{"key":"2770_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.2471\/BLT.08.055715","volume":"87","author":"GJ Hofmeyr","year":"2009","unstructured":"Hofmeyr GJ, G\u00fclmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ. 2009;87:666\u201377.","journal-title":"Bull World Health Organ"},{"key":"2770_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(01)05835-4","volume":"358","author":"AM G\u00fclmezoglu","year":"2001","unstructured":"G\u00fclmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet. 2001;358:689\u201395.","journal-title":"Lancet"},{"key":"2770_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0002-9378(99)70610-1","volume":"180","author":"DA Wing","year":"1999","unstructured":"Wing DA, Ham D, Paul RH. A comparison of orally administred misoprostol versus vaginally administred misoprostol for cervical ripening and labor inducion. Am J Obstet Gynecol. 1999;180:1155\u201360.","journal-title":"Am J Obstet Gynecol"},{"key":"2770_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/AOG.0b013e318209d669","volume":"117","author":"DA Wing","year":"2011","unstructured":"Wing DA, Miller H, Parker L, Powers BL, Rayburn WF. Misoprostol vaginal insert misoprostol. Obstet Gynecol. 2011;117:533\u201341.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2770_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00404-018-4942-y","volume":"299","author":"Markus Schmidt","year":"2018","unstructured":"Schmidt M, Neophytou M, Hars O, Freudenberg J, K\u00fchnert M. Clinical experience with misoprostol vaginal insert for induction of labor: a prospective clinical observational study. Arch Gynecol Obstet. 2018. https:\/\/doi.org\/10.1007\/s00404-018-4942-y [Epub ahead of print].","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"2770_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/AOG.0b013e318187042e","volume":"112","author":"DA Wing","year":"2008","unstructured":"Wing DA. Misoprostol vaginal insert compared with dinoprostone vaginal insert \u2013 a randomized controlled trial. Obstet Gynecol. 2008;112:801\u201312.","journal-title":"Obstet Gynecol"},{"key":"2770_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/AOG.0b013e31829a2dd6","volume":"122","author":"DA Wing","year":"2013","unstructured":"Wing DA, Brown R, Plante LA, Miller H, Rugarn O, Powers BL. Misoprostol vaginal insert and time to vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2013;122:201\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2770_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1515\/jpm-2018-0128","volume":"47","author":"Katharina Redling","year":"2019","unstructured":"Redling K, Schaedelin S, Huhn EA, Hoesli I. Efficacy and safety of misoprostol vaginal insert vs. oral misoprostol for induction of labor. J Perinat Med 2018. pii: \/j\/jpme.ahead-of-print\/jpm-2018-0128\/jpm-2018-0128.xml. doi: https:\/\/doi.org\/10.1515\/jpm-2018-0128. [Epub ahead of print].","journal-title":"Journal of Perinatal Medicine"},{"key":"2770_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1515\/jpm-2017-0049","volume":"46","author":"A Brandstetter","year":"2018","unstructured":"Brandstetter A, Henrich W, Rawnaq T, Hasselbeck H, D\u00f6bert TF, et al. The misoprostol vaginal insert compared with oral misoprostol for labor induction in term pregnancies: a pair-matched case-control study. J Perinat Med. 2018;46:309\u201316.","journal-title":"J Perinat Med"},{"key":"2770_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejogrb.2019.06.010","volume":"240","author":"A Sharp","year":"2019","unstructured":"Sharp A, Faluyi D, Alfirevic Z. Misoprostol vaginal insert (Mysodelle) versus Dinoprostone intravaginal gel (Prostin) for induction of labour. Eur J Obstet Gynecol Reprod Biol. 2019;240:41\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-2770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-020-2770-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-2770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T06:05:25Z","timestamp":1612764325000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-2770-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2770"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-2770-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"15 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the guidelines of the Declaration of Helsinki and was approved by the Regional Ethics Committee (no. 50213) Regional Medicines Agency and the Danish Data Protection Agency (REG-81-2015).The use of the two different regimens for induction of labour was approved by the Regional Medicines Agency as standard regimens for the two different departments, therefore individual consent for the choice of medication was not required \u2013 besides informed consent for induction of labour in general.All women who participated in the study were asked to fill out a questionnaire abort their birth experience before they left the department. In the end of this questionnaire they were asked for permission to collect information from their medical record. If they did not fill out the questionnaire, they were contacted by telephone and asked to answer the same questions including the question about collecting information from their medical record. The Regional Ethics committee approved the use of verbal consent for data collection, for patients contacted by telephone.All patients included in this study provided informed consent (verbal or written) to access their medical records, and this was collected and registered before data-collection was commenced, as approved by the ethics committee. The researcher accessing the information was\/is an authorised health care professional.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}